Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial" [Vaccine 40(19) (2022) 2705-2713].

Vaccine

Microbiology and Molecular Genetics, Vaccine Testing Center, University of Vermont Larner College of Medicine, Burlington, VT, USA.

Published: May 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168436	PMC
http://dx.doi.org/10.1016/j.vaccine.2022.05.001	DOI Listing

Publication Analysis

corrigendum "intradermal

"intradermal fractional-dose

fractional-dose inactivated

inactivated polio

polio vaccine

vaccine fipv

fipv adjuvanted

adjuvanted double

double mutant

mutant enterotoxigenic

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!